Invesco Management & Research Inc

GRT Capital Partners, LLC was founded in 2001 by Rudolph Kluiber, Gregory Fraser and Timothy Krochuk. The firm provides active equity management through the use of time-tested as well as new strategies for a diversified investor base. GRT Capital prides itself on its institutional approach to asset management, risk control and client service. Active management, by its very nature, is hard to do. The maintenance of an investing edge takes dedication and constant improvement in everything a firm does. For this reason, GRT combines the benefits of careful fundamental research, deep quantitative research and the latest technology. But there is no compass like experience, and all of the capability that is developed is guided by the best senior investment professionals from the Boston community who have come to GRT to do what they do best. Today, Rudolph Kluiber, Gregory Fraser and Timothy Krochuk are proud to have attracted twenty dedicated professionals, ten of whom are involved with asset management on a daily basis.

Frontier Capital Management Company is a full-service provider of investment management services for commercial and industrial customers. Founded in 1980, the company has a staff of trained and certified professionals who offer fundamental research, consulting, marketing and client services. It provides investment strategies for medium- and large-sized industries. Frontier Capital Management Company offers finance and compliance management services for its clients. The company provides various processes, such as capital appreciation and growth strategies. It is affiliate of Affiliated Managers Group, which is an asset management company. Affiliated Managers Group offers more than 300 investment products. Frontier Capital Management Company additionally offers small capital valuation services.

TVM Capital Life Science is a venture capital firm based in Boston, MA, specializing in funding and supporting innovative life science companies. With a mission to transform healthcare, they invest in breakthrough therapies and medical products that benefit patients and the healthcare system, providing capital and expertise to develop and market these products. Their unique approach includes financing early-stage therapeutics through a strategic partnership with global pharmaceutical firm Eli Lilly and Company, as well as investing in commercial-stage medtech, diagnostics, digital health products, and late-stage therapeutics. With a track record of successful collaborations, TVM Capital Life Science works closely with their portfolio companies to enable their ideas and bring new therapies and medical products to market.Generated from the website